Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods relating to myomaker-induced muscle cell fusion

Compositions and methods relating to myomaker-induced muscle cell fusion

US Patent 10272137 · Granted Apr 30, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of a small native peptide activator of SERCA pump for treatment of heart fai2025
Polypeptides, nucleic acid molecules, compositions, and related methods2024
Compositions and methods relating to myomaker-induced muscle cell fusion2022
Compositions and methods relating to myomaker-induced muscle cell fusion2022
NURR1 activation in the treatment of metabolic disorders and as an exercise mime2021
Use of a small native peptide activator of SERCA pump for treatment of heart fai2021
Generation and correction of a humanized mouse model with a deletion of dystroph2020
Use of a small native peptide activator of SERCA pump for treatment of heart fai2020
Micro-RNA family that modulates extracellular matrix genes and uses thereof2019
Modulation of MRTF-A activity in pathologic fibrosis and wound healing2018
Micro-RNA family that modulates fibrosis and uses thereof2017
Micro-RNA family that modulates fibrosis and uses thereof2017